PFIZER INCPFE

Market cap

$146.2B

P/E ratio

	Dec 31, 2010	Dec 31, 2011	Dec 31, 2012	Dec 31, 2013	Dec 31, 2014	Dec 31, 2015	Dec 31, 2016	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Product	-	-	-	-	-	-	-	-	-	664	284	590	-	-	53,816
Royalty	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,423
Revenues	67,809	67,425	58,986	51,584	49,605	48,851	52,824	52,546	53,647	51,750	41,908	81,288	100,330	58,496	63,627
Alliance revenues	-	-	-	-	-	-	-	-	-	-	-	-	-	7,582	8,388
Cost of sales	16,279	15,085	11,334	9,586	-	-	-	-	11,248	10,219	8,692	30,821	34,344	24,954	17,851
Selling, General and Administrative Expense	19,614	19,468	16,616	14,355	14,097	14,809	14,837	14,784	14,455	14,350	11,615	12,703	13,677	14,771	14,730
Research and development expenses	9,413	9,112	7,870	6,678	8,393	7,690	7,872	7,657	8,006	8,650	9,405	13,829	11,428	10,679	10,822
Acquired in-process research and development expenses	-	-	-	-	-	-	-	-	-	-	-	-	953	194	108
Amortization of intangible assets	-	-	5,175	4,599	4,039	3,728	4,056	4,758	4,893	4,610	3,436	3,700	3,609	4,733	5,286
Restructuring Charges And Acquisition Related Costs	3,214	2,934	1,880	1,182	250	1,152	1,724	487	1,044	747	600	802	1,375	2,943	2,419
Other (income)/deductions––net	-	-	-	-	-1,009	-2,860	-3,655	-1,315	-2,116	-3,578	-669	4,878	-217	835	-4,388
Income from continuing operations before provision/(benefit) for taxes on income	-	12,762	12,080	15,716	12,240	8,965	8,351	12,305	11,885	17,682	7,497	24,311	34,729	1,058	8,023
Income Tax Expense (Benefit)	1,124	4,023	2,562	4,306	3,120	1,990	1,123	-9,049	706	1,384	477	1,852	3,328	-1,100	-28
Income from continuing operations	8,298	8,739	9,518	11,410	9,119	6,975	7,229	21,353	11,179	16,298	7,021	22,459	31,401	2,172	8,051
Discontinued operations––net of tax	-9	1,312	5,080	10,662	48	11	17	2	10	4	2,631	-434	6	-15	11
Net income before allocation to noncontrolling interests	8,289	10,051	14,598	22,072	9,168	6,986	7,246	21,355	11,188	16,302	9,652	22,025	31,407	2,158	8,062
Less: Net income attributable to noncontrolling interests	32	42	28	69	32	26	31	47	36	29	36	45	35	39	31
Net income attributable to Pfizer Inc. common shareholders	8,289	10,051	14,598	22,072	9,168	6,986	7,246	21,355	11,188	16,302	9,652	22,025	31,407	2,158	8,062
Income (Loss) from Continuing Operations, Per Basic Share	1.03	1.11	1.27	1.67	1.43	1.13	1.18	3.57	1.9	2.92	1.26	4	5.59	0.38	1.42
Discontinued operations––net of tax (in dollars per share)	-	0.17	0.68	1.56	0.01	-	-	-	-	-	0.47	-0.08	-	-	-
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)	1.03	1.28	1.96	3.23	1.44	1.13	1.18	3.57	1.9	2.92	1.73	3.92	5.59	0.38	1.42
Income (Loss) from Continuing Operations, Per Diluted Share	1.02	1.11	1.26	1.65	1.41	1.11	1.17	3.52	1.86	2.87	1.24	3.93	5.47	0.37	1.41
Discontinued operations––net of tax (in dollars per share)	-	0.17	0.68	1.54	0.01	-	-	-	-	-	0.47	-0.08	-	-	-
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)	1.02	1.27	1.94	3.19	1.42	1.11	1.17	3.52	1.87	2.87	1.71	3.85	5.47	0.37	1.41